Madecassic acid
CAS No. 18449-41-7
Madecassic acid( —— )
Catalog No. M18146 CAS No. 18449-41-7
Madecassic acid is extracted from the whole herb of Centella asiatica.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 71 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMadecassic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMadecassic acid is extracted from the whole herb of Centella asiatica.
-
DescriptionMadecassic acid is extracted from the whole herb of Centella asiatica.
-
In VitroWestern Blot Analysis Cell Line:RAW 264.7 murine macrophage cell Concentration:50, 100, 150 μM Incubation Time:24 h followed by LPS (1 μg/mL) treatment for 4 h Result:Inhibited LPS-induced iNOS and COX-2 protein expression i in a dose -dependent manner.
-
In VivoAnimal Model:Colitis mice induced by2.5% DSS Dosage:25?mg/kg/day Administration:Oral gavage (p.o.) , 10 days Result:Decreased the number of γδT17 cells in the colons.Reduced the expression of IL-17 in colon tissues.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number18449-41-7
-
Formula Weight504.71
-
Molecular FormulaC30H48O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (123.84 mM)
-
SMILESC[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(C[C@H]([C@@H]3[C@@]4(C[C@H]([C@@H]([C@@]3(C)CO)O)O)C)O)C)[C@@H]2[C@H]1C)C)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. J BUON. 2014 Apr-Jun;19(2):372-6.
molnova catalog
related products
-
Lactobionic acid
Lactobionic acid with antioxidant antimicrobial and moisturizing propertie.
-
Naringin 4-glucoside
Naringin 4'-glucoside has antioxidant ability.
-
Tinurilimab
Tinurilimab (Bay 1834942) is a monoclonal antibody that targets and inhibits CEACAM6, an immune checkpoint regulator. Tinurilimab can be used in studies about effector T-cells against tumors.
Cart
sales@molnova.com